“accurins” Archives

in
Entry Author Date Location
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M 07/06/16 Boston
Bind Therapeutics Sheds Employees, Considers New Capital or Deals 04/06/16 Boston
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Page 1 of 1